Disease activity after natalizumab discontinuation in multiple sclerosis: reactivation or rebound?

被引：0
|
作者：
Borriello, G. [1 ]
Prosperini, L. [1 ]
Mancinelli, C. [1 ]
Fubelli, F. [1 ]
Gianni, C. [1 ]
Marinelli, F. [1 ]
Pozzilli, C. [1 ]
机构：
[1] S Andrea Hosp, Rome, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2011年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P529
引用
下载
收藏
页码：S228 / S228
页数：1
相关论文
共 50 条
  • [1] Reactivation of disease activity in patients with multiple sclerosis after Natalizumab discontinuation: a case report in Venezuela
    Soto, I
    Ferrer, O.
    Molina, O.
    Mora, E.
    Villalobos, V.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (12) : 1860 - 1860
  • [2] Catastrophic multiple sclerosis rebound after natalizumab treatment discontinuation
    Tur, C.
    Tintore, M.
    Vidal-Jordana, A.
    Rio, J.
    Wing, A. C.
    Canneti, B.
    Torres, M.
    Arevalo, M. J.
    Castillo, J.
    Galan, I.
    Horno, R.
    Vicente, M. J.
    Martin, M. I.
    Comabella, M.
    Rovira, A.
    Sastre-Garriga, J.
    Montalban, X.
    JOURNAL OF NEUROLOGY, 2013, 260 : S14 - S14
  • [3] Cognitive impairment rebound in multiple sclerosis patients after natalizumab discontinuation
    Iaffaldano, P.
    Viterbo, R. G.
    Direnzo, V.
    D'Onghia, M.
    Tortorella, C.
    Paolicelli, D.
    Trojano, M.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 532 - 532
  • [4] Risk factors for reactivation of multiple sclerosis after discontinuation of natalizumab treatment
    Mustonen, T.
    Rauma, I.
    Hartikainen, P.
    Kruger, J.
    Niiranen, M.
    Selander, T.
    Simula, S.
    Remes, A.
    Kuusisto, H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 687 - 687
  • [5] Rebound after natalizumab discontinuation
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 32 - 33
  • [6] Risk factors for reactivation of clinical disease activity in multiple sclerosis after natalizumab cessation
    Mustonen, Tiina
    Rauma, Ilkka
    Hartikainen, Paivi
    Kruger, Johanna
    Niiranen, Marja
    Selander, Tuomas
    Simula, Simula
    Anne, Remes M.
    Kuusisto, Hanna
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 38
  • [7] Natalizumab discontinuation is associated with a rebound of cognitive impairment in multiple sclerosis patients
    Pietro Iaffaldano
    Rosa Gemma Viterbo
    Maria Trojano
    Journal of Neurology, 2016, 263 : 1620 - 1625
  • [8] Natalizumab discontinuation is associated with a rebound of cognitive impairment in multiple sclerosis patients
    Iaffaldano, Pietro
    Viterbo, Rosa Gemma
    Trojano, Maria
    JOURNAL OF NEUROLOGY, 2016, 263 (08) : 1620 - 1625
  • [9] Natalizumab discontinuation is associated to a rebound of cognitive impairment in multiple sclerosis patients
    Iaffaldano, P.
    Viterbo, R. G.
    Paolicelli, D.
    Direnzo, V.
    D'Onghia, M.
    Trojano, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 154 - 154
  • [10] Multiple Sclerosis Disease Activity and Disability Following Discontinuation of Natalizumab for Pregnancy
    Hellwig, Kerstin
    Tokic, Marianne
    Thiel, Sandra
    Esters, Nina
    Spicher, Charlotte
    Timmesfeld, Nina
    Ciplea, Andrea, I
    Gold, Ralf
    Langer-Gould, Annette
    JAMA NETWORK OPEN, 2022, 5 (01) : E2144750
12345